Skip to content
Recall Observatory FDA recall evidence

Drug product

Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-451-17

D-0521-2025

June 20, 2025

Class II

Product summary

Firm
ACCORD HEALTHCARE, INC.
Event
Event 97103
Status
Ongoing
Classification
Class II
Quantity
9,739 bottles
Official record key
drug-enforcement:D-0521-2025

Official wording

Reason: Subpotent Drug: Assay below the approved specification

Code information: Lot #D2300092, Exp Date: 12/31/2025; Lot #D2400722, Exp Date: 03/31/2026

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent